Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Jetstream Venture Fund announced in a press release new portfolio investments in ImageAiD and Moonrise Medical, two healthtech companies building AI vascular diagnostic tools for Peripheral Artery Disease.
ImageAiD combines Mayo Clinic validated research, a handheld Doppler device, and predictive AI software to help detect Peripheral Artery Disease before physical symptoms appear in primary care settings.
Moonrise Medical automates Doppler ultrasound assessments and Pedal Acceleration Time calculations. The company says its platform is designed to help clinicians evaluate vascular health without specialized sonographers.
Jetstream said Peripheral Artery Disease affects more than 200 million people globally and 12 million people in the United States. The fund did not disclose the size of the investments.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 11 Evergreen Digital Media Invests in Adwave and Licenses AI Ad Platform Sep 11 Rime to Power Dialpad Voice AI Products Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 Zettabyte and Raku Plan Renewable Energy AI Data Centers in Asia Sep 11 DCM Services and AKUVO Partner on Estate RecoveryMore from Funding
Sep 12 Nscale Adds Fidji Simo to a Board Built for Scale Sep 11 Evergreen Digital Media Invests in Adwave and Licenses AI Ad Platform Sep 11 Intermezzo Raises $10 Million for Global Payroll Platform Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 FAZE Security Emerges From Stealth With $6 Million Seed RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Metriport Raises $26 Million for Patient Record Platform
fileAI Gets Investment From SMBC Asia Rising Fund and Singtel Innov8
UrgentIQ Raises $15 Million for AI Clinical Workflows
AI Score Raises $5.4 Million for AI Governance Platform
Daily AI Brief: the AI news that matters, in your inbox.